When faced with infertility, Amanda and Jeff Walker had a baby through in vitro fertilization but were left with extra embryos — and questions. Tori and Sam Earle “adopted” an embryo frozen 20 years ...

No dog ever had a better yard to play in than Drago. Because as countless Boston Red Sox players and fans saw over the last decade, Drago’s playground was Fenway Park. Sniffing along the Green Monster ...

(Reuters) -Russia plans to take full control of Donbas and southern Ukraine during the second phase of what it calls its special military operation, the deputy commander of Russia’s central military ...

(Reuters) -Broadcom on Thursday made its biggest and boldest move to diversify its business, with a $61 billion offer for VMware Inc . Buying VMware would be Broadcom’s most ambitious attempt at a ...

BERLIN (Reuters) – Turkey’s foreign minister criticised on Saturday the “unacceptable and outrageous” support that prospective new NATO members Sweden and Finland give to the PKK Kurdish militant ...

(Reuters) -Industrial materials maker DuPont de Nemours said it expects slower sales volume growth and sequential margin contraction in the current quarter as COVID-related shutdowns in China further ...

BRUSSELS (Reuters) – Far-right leader Marine Le Pen looks unlikely to win France’s presidential election, but many western allies fear an upset on Sunday that could jolt the international order no ...

(Reuters) – The United Arab Emirates announced on Tuesday the first case of monkeypox detected in the country, state news agency WAM reported, citing the health ministry. The virus was detected in a ...

(Reuters) – Rafa Nadal said his recovery from a rib injury has been like a “roller coaster” after the 21-times major winner returned to action with a win over Miomir Kecmanovic at the Madrid Open. The ...

(Reuters) – Eight people died in Russian attacks in Ukraine’s Luhansk region on Saturday, Serhiy Gaidai, the region’s governor, wrote in a post on social media. Reuters was not able to immediately ...

(Reuters) -Biogen Inc said on Friday it will withdraw the marketing application for its controversial Alzheimer’s drug, aducanumab, in Europe after the U.S. biotech company failed to convince the ...